Clinical efficacy and safety: nervous system

The European Medicines Agency's scientific guidelines on the clinical evaluation of medicines used in nervous-system disorders help medicine developers prepare marketing authorisation applications for human medicines.

If you have comments on a document which is open for consultation, use the Microsoft Office document iconform for submission of comments on scientific guidelines .

Please submit your comments to the following email address: cnswpsecretariat@ema.europa.eu.

For a complete list of scientific guidelines currently open for consultation, see Public consultations.

Guidelines


Points to consider

How useful was this page?

Add your rating